Product image of Medaxone Plusolv (Ceftriaxone) supplied by GNH India

Medaxone Plusolv

Active Ingredient:
Ceftriaxone
Origin:
EU

Medaxone Plusolv (Ceftriaxone)

Ceftriaxone, the active ingredient in Medaxone Plusolv, is a third‑generation cephalosporin presented as a sterile powder for reconstitution for intravenous use. It treats a broad range of serious bacterial infections in adult and pediatric patients under medical supervision.

GNH India supplies Medaxone Plusolv as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring regulatory compliance and reliable cold‑chain logistics where required. The company adheres to WHO‑GMP standards and provides comprehensive documentation for import and distribution.

Manufacturer / TM Owner

Medochemie Ltd.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Ceftriaxone is employed for a variety of serious bacterial infections affecting multiple organ systems.

  • Community‑acquired pneumonia: effective against common respiratory pathogens, reducing disease severity.
  • Bacterial meningitis: penetrates the cerebrospinal fluid to eradicate causative organisms.
  • Gonorrhea (uncomplicated): provides a single‑dose cure for Neisseria gonorrhoeae infections.
  • Urinary tract infections: treats complicated UTIs caused by susceptible Gram‑negative bacteria.
  • Intra‑abdominal infections: covers mixed aerobic and anaerobic organisms in peritonitis and abscesses.

How It Works

  • Ceftriaxone binds to penicillin‑binding proteins on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. Its high affinity for a broad spectrum of Gram‑negative and some Gram‑positive organisms underlies its clinical efficacy.

Side Effects

Ceftriaxone may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Injection site pain or phlebitis.
  • Diarrhea.
  • Rash or mild skin eruption.
  • Nausea.
  • Vomiting.
  • Transient elevation of liver enzymes.

Serious or Rare Side Effects

  • Clostridioides difficile‑associated colitis.
  • Anaphylaxis or severe hypersensitivity reactions.
  • Stevens‑Johnson syndrome/toxic epidermal necrolysis.
  • Hemolytic anemia.
  • Acute renal impairment.
  • Severe hepatic dysfunction.

Precautions & Warnings

Ceftriaxone requires careful monitoring in specific clinical situations.

  • Renal function: adjust use in patients with severe renal impairment.
  • Hepatic function: monitor liver enzymes during prolonged therapy.
  • Calcium‑containing solutions: avoid concurrent IV administration to prevent precipitation.
  • Pregnancy and lactation: use only if benefits outweigh potential risks.
  • Allergy: discontinue immediately if hypersensitivity develops.
  • Store at below 25°C: keep in the original packaging, protect from moisture and light.

Avoid Interactions

Ceftriaxone can interact with several medicines, necessitating vigilance.

Major Interactions (Avoid)

  • Calcium‑containing IV solutions: risk of insoluble precipitate, especially in neonates.
  • Warfarin: potentiates anticoagulant effect, requiring INR monitoring.
  • Aminoglycosides: increased risk of nephrotoxicity when co‑administered.
  • Oral contraceptives: reduced efficacy, consider alternative contraception.
  • Live bacterial vaccines: diminished vaccine effectiveness.

Moderate Interactions (Monitor Closely)

  • Diuretics: may exacerbate electrolyte disturbances.
  • Other antibiotics (e.g., bacteriostatic agents): potential antagonism, assess therapeutic need.
  • Antacids: may alter absorption if oral formulation is used, monitor clinical response.

Frequently Asked Questions

Medaxone Plusolv contains ceftriaxone, which is indicated for serious bacterial infections such as community‑acquired pneumonia, bacterial meningitis, gonorrhea, complicated urinary tract infections, and intra‑abdominal infections caused by susceptible organisms.

Ceftriaxone inhibits bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, blocking the cross‑linking of peptidoglycan strands. This weakens the cell wall, leading to osmotic rupture and bacterial death.

The dosage of Medaxone Plusolv is determined by the prescribing clinician based on the type and severity of infection, patient age, weight, renal and hepatic function, and local treatment guidelines.

The pregnancy category for ceftriaxone is unknown. It should be used in pregnancy or while breastfeeding only when the potential benefit justifies any potential risk to the fetus or infant, and under medical supervision.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Ceftriaxone offers a long half‑life that allows once‑daily dosing, which can be advantageous over agents like cefotaxime that require more frequent administration. Its broad spectrum covers many Gram‑negative and some Gram‑positive pathogens, but susceptibility testing remains essential to guide therapy.

Medaxone Plusolv should be stored at temperatures below 25 °C, in its original packaging, protected from moisture and light. Reconstituted solutions must be used promptly or stored according to the manufacturer’s instructions.

The product is supplied as a sterile powder for reconstitution and is administered intravenously by a qualified healthcare professional, typically as an infusion over 30 minutes or as directed by the prescriber.

Serious risks include Clostridioides difficile‑associated colitis, severe hypersensitivity reactions such as anaphylaxis, Stevens‑Johnson syndrome, hemolytic anemia, and significant renal or hepatic impairment. Immediate medical attention is required if any of these occur.

Patients with a known hypersensitivity to ceftriaxone, other cephalosporins, or β‑lactam antibiotics should avoid this product. Neonates (≤28 days) requiring calcium‑containing IV solutions should not receive ceftriaxone concurrently due to precipitation risk.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Ceftriaxone

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT